Physician profile
Paresh Dandona
NPI 1144217621
$109,474.47
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $42K · 2021: $4,095 · 2023: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $63,495.94 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $30,996.05 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $7,803.46 | 2020 | |
| Clarus Therapeutics INC. | $4,950.00 | 2020 | |
| Marius Pharmaceuticals, INC | $2,000.00 | 2023 | |
| Antares Pharma, INC. | $129.62 | 2019 | |
| Merck Sharp & Dohme LLC | $60.00 | 2019 | |
| Lilly USA, LLC | $28.20 | 2019 | |
| Pfizer INC. | $11.20 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paresh Dandona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.